N4 Pharma (N4P) News Today → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free N4P Stock Alerts GBX 0.80 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsStock AnalysisChartCompetitors All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 26, 2024 | lse.co.ukN4 Pharma strikes partnership deal for intracellular deliveryApril 19, 2024 | lse.co.ukN4 Pharma sees potential in Nuvec delivery method for cancer treatmentJanuary 24, 2024 | lse.co.ukN4 Pharma Plc Share ChatSeptember 28, 2023 | marketwatch.comN4 Pharma Acquires Major Stake in Nanogenics Through Discounted Share Placing; Shares FallJuly 25, 2023 | marketwatch.comN4 Pharma Shares Rise After Further Nuvec Patent Granted in USApril 26, 2023 | marketwatch.comN4 Pharma Shares Rise on Development of Nuvec TestMarch 9, 2023 | marketwatch.comN4 Pharma's Pretax Loss Narrowed in 2022 on Lower R&D CostsFebruary 26, 2023 | seekingalpha.comMicrocap Timber Pharmaceuticals up 46% on orphan drug designation for skin disorder drugJanuary 18, 2023 | marketwatch.comN4 Pharma Shares Rise on Positive Nuvec Oral Application ResultsNovember 1, 2022 | marketwatch.comN4 Pharma Enhances Nuvec's Application Claims in Bid to Gain Patent ProtectionOctober 11, 2022 | finance.yahoo.comInstitutions profited after N4 Pharma Plc's (LON:N4P) market cap rose UK£2.9m last week butindividual investors profited the mostOctober 4, 2022 | marketwatch.comN4 Pharma Shares Rise on Successful Testing of Nuvec, Vaccine SystemSeptember 29, 2022 | marketwatch.comN4 Pharma Narrows 1H Loss by Controlling Expenditure; Shares RiseSeptember 3, 2022 | uk.investing.comFTSE South Africa Technical AnalysisAugust 13, 2022 | finance.yahoo.comN4 Pharma Plc (N4P.L)July 15, 2022 | marketwatch.comN4 Pharma Shares Rise on Further Nuvec ProgressJune 13, 2022 | marketwatch.comN4 Pharma Shares Rise on Positive Results for Nuvec Delivery SystemMarch 31, 2022 | finance.yahoo.comBeroni Group Announces Appointment of Dr. John Chiplin to Board of DirectorsJanuary 31, 2022 | marketwatch.comN4 Pharma Says Nuvec Granted Patents in U.S., ChinaJanuary 25, 2022 | marketwatch.comN4 Pharma to Work on Nuvec With Medicines Discovery Catapult Following Encouraging ResultsDecember 13, 2021 | marketwatch.comN4 Pharma to Focus Resources on Advancing Gene Therapy WorkAugust 30, 2021 | finance.yahoo.comWe Think N4 Pharma (LON:N4P) Can Afford To Drive Business GrowthAugust 24, 2021 | marketwatch.comN4 Pharma Says Nuvec Studies Are Progressing Well Get N4 Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for N4P and its competitors with MarketBeat's FREE daily newsletter. Email Address The CHIPS Act Motherlode (Ad)If you haven’t heard yet, the CHIPS Act is the US government pouring $280 BILLION into the manufacturing of US semiconductors. A lot of companies will make a fortune from this. Click here to see my #1 investment for 2024. N4P Media Mentions By Week N4P Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. N4P News Sentiment▼0.000.42▲Average Medical News Sentiment N4P News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. N4P Articles This Week▼00▲N4P Articles Average Week Get N4 Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for N4P and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ReNeuron Group News Physiomics News Oxford Cannabinoid Technologies News Fusion Antibodies News Evgen Pharma News IQ-AI News IXICO News ValiRx News Surgical Innovations Group News genedrive News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:N4P) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressShocking $16T Elon Musk Crypto LeakCrypto 101 Media[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding N4 Pharma Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
